The effects of omega‐3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta‐analysis

• Main Authors: Ernesto Calderon Martinez (Author), Stephin Zachariah Saji (Author), Jonathan Victor Salazar Ore (Author), Omar A. Borges‐Sosa (Author), Samyuktha Srinivas (Author), Naga Sai Rasagna Mareddy (Author), Tanseem Manzoor (Author), Mariela Di Vanna (Author), Yasemin Al Shanableh (Author), Rishabh Taneja (Author), Victor Sebastian Arruarana (Author)
• Format: Book
• Published: Wiley, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Alzheimer's disease (AD) is the most common cause of dementia worldwide. Omega‐3 fatty acids (n‐3‐PUFA) are essential to normal neural development and function. Souvenaid®, a medical supplement that contains n‐3‐PUFA's: eicosatetraenoic acid (EPA) and docosahexaenoic ac...